↓ Skip to main content

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

Overview of attention for article published in Molecular Cancer, July 2010
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#3 of 1,940)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
154 Dimensions

Readers on

mendeley
230 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Published in
Molecular Cancer, July 2010
DOI 10.1186/1476-4598-9-196
Pubmed ID
Authors

María M Caffarel, Clara Andradas, Emilia Mira, Eduardo Pérez-Gómez, Camilla Cerutti, Gema Moreno-Bueno, Juana M Flores, Isabel García-Real, José Palacios, Santos Mañes, Manuel Guzmán, Cristina Sánchez

X Demographics

X Demographics

The data shown below were collected from the profiles of 191 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 230 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
United Kingdom 2 <1%
South Africa 1 <1%
Brazil 1 <1%
Unknown 223 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 42 18%
Researcher 35 15%
Student > Ph. D. Student 28 12%
Student > Master 25 11%
Other 18 8%
Other 41 18%
Unknown 41 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 43 19%
Biochemistry, Genetics and Molecular Biology 39 17%
Medicine and Dentistry 30 13%
Pharmacology, Toxicology and Pharmaceutical Science 12 5%
Psychology 8 3%
Other 45 20%
Unknown 53 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 420. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2024.
All research outputs
#69,687
of 25,595,500 outputs
Outputs from Molecular Cancer
#3
of 1,940 outputs
Outputs of similar age
#128
of 105,130 outputs
Outputs of similar age from Molecular Cancer
#1
of 35 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,940 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,130 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.